Johnson & Johnson (JNJ) PT, Estimates Cut at BofA/Merrill Lynch Post Q3

October 15, 2014 7:23 AM

BofA/Merrill Lynch analyst Bob Hopkins lowered his price target on Johnson & Johnson (NYSE: JNJ) to $99.00 (from $106.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found